Derlin-1 Is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy

Clinical Cancer Research

Volumn 14, Issue 20, 2008, Pages 6538-6545

  Ran, Yuliang ^a   Hu, Hai ^a   Hu, Dong ^a   Zhou, Zhuan ^a   Sun, Yuemin ^b   Yu, Long ^a   Sun, Lixin ^a   Pan, Jian ^a   Liu, Jun ^a   Liu, Tong ^a   Yang, Zhihua ^a,b  

^a Departments of Cell and Molecular Biology   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DERLIN 1; HOMODIMER; IODINE 125; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY CONJUGATE; DERL1 PROTEIN, HUMAN; PEPTIDE FRAGMENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CLINICAL FEATURE; FEMALE; GAMMA SCINTIGRAPHY; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CELL PROLIFERATION; CYTOPLASM; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; METABOLISM; NEOPLASM; NUDE MOUSE; RABBIT; TISSUE DISTRIBUTION; TISSUE MICROARRAY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL MEMBRANE; CELL PROLIFERATION; CYTOPLASM; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOCONJUGATES; IODINE RADIOISOTOPES; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASMS; PEPTIDE FRAGMENTS; RABBITS; RADIOPHARMACEUTICALS; TISSUE ARRAY ANALYSIS; TISSUE DISTRIBUTION;

EID: 58149190790     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0476     Document Type: Article

References (34)

1. Oshimi K, Seto T, Oshimi Y, Masuda M, Okumura K, Mizoguchi H. Increased lysis of patient CD10-positive leukemic cells by Tcells coated with anti-CD3 Fab′ antibody cross-linked to anti-CD10 Fab′ antibody. Blood 1991;77:1044-9.
2. Mach JP, Pelegrin A, Folli S, Buchegger F. Radiolabeled monoclonal antibodies as anti-tumor missiles, their diagnostic success and therapeutic potential. Bull Acad Natl Med 1992;176:879-89.
3. Begent RH,Verhaar MJ, Chester KA, et al. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. NatMed1996;2:979-84.
4. Scott AM, Welt S. Antibody-based immunological therapies. Curr Opin Immunol 1997;9:717-22.
5. Lilley BN, Ploegh HL. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004;429:834-40.
6. Ye Y Shibata Y, Yun C, Ron D, Rapoport TA. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004;429:841-7.
7. Sun F, Zhang R, Gong X, Geng X, Drain PF, Frizzell RA. Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants. J Biol Chem 2006;281:36856-63.
8. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, Walter P. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 2000;101:249-58.
9. Wang J, Hua H, Ran Y, et al. Derlin-1 is overexpressed in human breast carcinoma and protects cancer cells from endoplasmic reticulum stress-induced apoptosis. Breast Cancer Res 2008;10:R7.
10. Fels DR, Koumenis C. The PERK/eIF2α/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther 2006;5:723-8.
11. Bi M, Naczki C, Koritzinsky M, et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 2005;24:3470-81.
12. Romero-Ramirez L, Cao H, Nelson D, et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res 2004;64:5943-7.
13. Koong AC, Chauhan V, Romero-Ramirez L.Targeting XBP-1 as a novel anti-cancer strategy. Cancer Biol Ther 2006;5:756-9.
14. Park HR, Tomida A, Sato S, et al. Effect on tumor cells of blocking survival response to glucose deprivation. J Natl Cancer Inst 2004;96:1300-10.
15. Shin BK, Wang H, Yim AM, et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 2003;278:7607-16.
16. Melendez K, Wallen ES, Edwards BS, Mobarak CD, Bear DG, Moseley PL. Heat shock protein 70 and glycoprotein 96 are differentially expressed on the surface of malignant and nonmalignant breast cells. Cell Stress Chaperones 2006;11:334-42.
17. Tamura Y, Peng P, Liu K, Daou M, Srivastava PK. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science (NY) 1997;278:117-20.
18. Mintz PJ, Kim J, Do KA, et al. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 2003;21:57-63.
19. Altmeyer A, Maki RG, Feldweg AM, et al. Tumor-specific cell surface expression of the-KDEL containing, endoplasmic reticular heat shock protein gp96. Int J Cancer 1996;69:340-9.
20. Liu Y, Steiniger SC, Kim Y, Kaufmann GF, Felding-Habermann B, Janda KD. Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery. Mol Pharm2007;4:435-47.
21. Sauk JJ, Coletta RD, Norris K, Hebert C. Binding motifs of CBP2 a potential cell surface target for carcinoma cells. J Cell Biochem 2000;78:251-63.
22. Arap MA,Lahdenranta J, Mintz PJ, et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004;6:275-84.
23. Dewji NN, Valdez D, Singer SJ. The presenilins turned inside out: implications for their structures and functions. Proc Natl Acad Sci U S A 2004;101: 1057-62.
24. Mason PW, Lu ML, Jacobson BS. Cell substrate adhesion-induced redistribution of proteins among the apical, basal, and internal domains of the plasma membrane of HeLa cells spreading on gelatin. J Biol Chem1987;262:3746-53.
25. Fraker PJ, Speck JC, Jr. Protein and cell membrane iodinations with a sparingly soluble chloroa-mide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978;80:849-57.
26. McIntosh DP,Tan XY, Oh P, Schnitzer JE. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A 2002;99:1996-2001.
27. Wu AM, Williams LE, Zieran L, et al. Anti-carcinoem-bryonic antigene (CEA) diabody for rapid tumor targeting and imaging. Tumor Targeting 1999;4:47-58.
28. Oda Y, Okada T, Yoshida H, Kaufman RJ, Nagata K, Mori K. Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J Cell Biol 2006;172:383-93.
29. Ye Y, Shibata Y, Kikkert M, van Voorden S, Wiertz E, Rapoport TA. Inaugural article. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslo-cation at the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A 2005;102:14132-8.
30. Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res 2005;3:597-605.
31. Revillion F, Bonneterre J, Peyrat J P. ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer 1998;34:791-808.
32. Baselga J, Seidman AD, Rosen PP, Norton L. HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications. Oncology (Huntingt) 1997;11:43-8.
33. Lilley BN, Ploegh HL. Multiprotein complexes that link dislocation, ubiquitination, and extraction of mis-folded proteins from the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A 2005;102:14296-301.
34. Ran Y, Jiang Y, Zhong X, et al. Identification of derlin-1 as a novel growth factor-responsive endothelial antigen by suppression subtractive hybridization. Biochem Biophys Res Commun 2006;348:1272-8.